IRIS
GRASSO, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.141
EU - Europa 8.276
AS - Asia 5.046
SA - Sud America 2.005
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
AN - Antartide 1
Totale 32.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.006
RU - Federazione Russa 2.751
SG - Singapore 1.986
BR - Brasile 1.787
IE - Irlanda 1.460
SE - Svezia 1.244
CN - Cina 1.216
VN - Vietnam 854
UA - Ucraina 728
IT - Italia 604
DE - Germania 568
HK - Hong Kong 522
FI - Finlandia 303
GB - Regno Unito 246
IN - India 111
FR - Francia 75
AR - Argentina 72
CA - Canada 62
TR - Turchia 55
AT - Austria 50
BD - Bangladesh 49
ZA - Sudafrica 43
CZ - Repubblica Ceca 41
BE - Belgio 39
MX - Messico 39
EC - Ecuador 38
NL - Olanda 36
MA - Marocco 34
IQ - Iraq 33
UZ - Uzbekistan 33
CO - Colombia 26
PL - Polonia 26
IR - Iran 25
VE - Venezuela 24
ES - Italia 20
ID - Indonesia 20
PK - Pakistan 20
CL - Cile 17
TN - Tunisia 17
DZ - Algeria 15
CI - Costa d'Avorio 14
PY - Paraguay 14
JP - Giappone 13
AE - Emirati Arabi Uniti 12
PE - Perù 12
UY - Uruguay 12
LV - Lettonia 11
NP - Nepal 11
RO - Romania 11
CH - Svizzera 10
IL - Israele 10
JM - Giamaica 10
AZ - Azerbaigian 9
EG - Egitto 9
EU - Europa 8
GE - Georgia 8
SN - Senegal 8
KG - Kirghizistan 7
LT - Lituania 7
SA - Arabia Saudita 7
BY - Bielorussia 6
JO - Giordania 6
KE - Kenya 6
KZ - Kazakistan 6
AL - Albania 5
AM - Armenia 5
KR - Corea 5
PA - Panama 5
TT - Trinidad e Tobago 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
LU - Lussemburgo 3
OM - Oman 3
RS - Serbia 3
BG - Bulgaria 2
BO - Bolivia 2
HU - Ungheria 2
MD - Moldavia 2
ML - Mali 2
MY - Malesia 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
DM - Dominica 1
Totale 32.623
Salva come PNG Salva come JPEG
Città #
Dallas 9.876
Dublin 1.458
Moscow 1.420
Jacksonville 1.377
Chandler 949
Singapore 943
Nyköping 812
Ashburn 659
Dong Ket 629
Beijing 532
Hong Kong 520
Princeton 265
Cambridge 254
Medford 232
Dearborn 216
Des Moines 188
Los Angeles 182
Boardman 152
The Dalles 150
Ann Arbor 143
Messina 140
São Paulo 118
Buffalo 113
Milan 95
Munich 89
Ho Chi Minh City 88
San Mateo 75
Lancaster 69
Jinan 68
Tianjin 67
New York 66
Wilmington 58
Redondo Beach 57
Rio de Janeiro 54
Woodbridge 54
Belo Horizonte 49
Hanoi 47
Vienna 47
Shenyang 45
Brooklyn 36
Brussels 36
Nanjing 36
Brno 35
Houston 35
Porto Alegre 31
Tashkent 31
Augusta 30
Haikou 27
Johannesburg 27
Pune 26
Zhengzhou 25
Amsterdam 24
Helsinki 24
Hyderabad 24
Stockholm 24
Brasília 23
Campinas 23
Chicago 23
Seattle 23
Warsaw 23
Santa Clara 22
Curitiba 21
Fuzhou 21
Taizhou 21
Turku 21
Hebei 19
Montreal 19
Ningbo 19
Salvador 19
St Petersburg 19
Ardabil 18
Changsha 17
Guangzhou 17
London 17
Boston 15
Nanchang 15
Norwalk 15
Quito 15
Abidjan 14
Da Nang 14
Denver 14
Dhaka 14
Guarulhos 14
Istanbul 14
Manaus 14
Poplar 14
Goiânia 13
Mumbai 13
Nova Iguaçu 13
Rome 13
Shenzhen 13
Toronto 13
Chennai 12
Hangzhou 12
Jiaxing 12
Montevideo 12
Orem 12
San Francisco 12
Washington 12
Ankara 11
Totale 23.557
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.693
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.664
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 252
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 245
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 242
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 231
1-(2-Fluorophenyl)- and 1-(3-fluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole 225
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 218
1-Adamantanamine derivatives as potential anti-HIV agents 217
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 214
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 187
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni 3a-sostituiti 168
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 161
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni isomeri ottenuti da 4-cloro-1,2-fenilendiamina ed acidi 3-acilpropionici 156
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 156
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 155
Cap. 21 - Antitrombotici 154
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 153
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 151
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 147
3,5-Dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel noncompetitive AMPA receptor antagonists 145
Derivati adamantanici a potenziale attività antivirale. 141
2,3-Benzodiazepines as potential AMPA receptors antagonists 139
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 138
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 138
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 135
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 134
4,4-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 132
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 132
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 131
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 130
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 130
A simple and efficient synthesis of GYKI 52466 and GYKI 52895 127
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 127
6,7-Methylenedioxyphtalazin-1(2H)-ones as novel and potent anticonvulsant agents 126
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 125
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 124
Annelated 1,5-benzothiazepines 123
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 122
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 122
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 122
Evaluation of curcumin irreversibility 118
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 116
4,5-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 115
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 115
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 115
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 114
6,7-Methylenedioxyquinazolin-4-ones as Anticonvulsant Agents 113
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 113
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 113
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 112
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 112
6,7-Metilendiossiftalazin-1(2H)-oni: una nuova classe di potenti agenti anticonvulsivanti. 112
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 112
Development of novel amides as non covalent inhibitors of immunoproteasome 112
Vincamina: sintesi e caratteristiche spettroscopiche 111
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 110
Falcipain-2 inhibitors 108
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 108
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 107
6,7-Methylenedioxyphthalazin-1(2H)-ones as novel and potent anticonvulsant agents 106
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 105
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 105
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 105
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 103
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 103
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 102
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 101
STRATEGIES FOR SYNTHESIS OF CONFORMATIONALLY CONSTRAINED GLUTAMATE ANALOGUES 101
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 101
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 101
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 100
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 100
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 100
Sintesi ed attività di nuovi agenti antiipertensivi. 99
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 99
Development of peptidomimetic boronates as proteasome inhibitors 99
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 98
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 98
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 97
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 97
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 97
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 97
2,3-Benzodiazepine-based noncompetitive AMPAR antagonists: design, synthesis, binding affinity and mechanism of inhibition of the GluR2Qflip homomeric receptor channel 97
Composti a presumibile attività antitumorale. IV - Sintesi ed attività antileucemica di N,N'-di-[2-(1,3,4-tiadiazolil)]metilendiamine 1-sostituite 96
Synthesis of 2-semicarbazonomethyl-4,5-methylenedioxyphenylacetic acids as anticonvulsant agents 95
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 95
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino,3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent 95
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 95
Glutamate Binding-Site Ligands of NMDA Receptors 95
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 94
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 94
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 94
Synthesis and structure-activity relationship of 2,3-benzodiazepines AMPA receptor antagonists 94
Synthesis and anticonvulsant activity of novel and potent 2,3- benzodiazepine AMPA/kainate receptor antagonists 93
Characterization of the binding site in a series of AMPA receptor antagonists. 93
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 93
The reaction between 3-acylpropionic acids and the o-phenylenediamine: n.m.r and X-ray analysis of 3a-phenyl-2,3,3a,4-tetrahydropyrrolo[1,2-a]benzimidazol-1-one. 91
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 91
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 91
Totale 21.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.567 0 0 0 0 0 211 10 215 70 213 164 684
2021/20221.643 10 350 30 70 86 2 103 61 36 61 295 539
2022/20234.222 367 326 182 300 328 467 84 224 1.779 16 98 51
2023/2024847 91 127 69 198 93 92 16 31 4 46 14 66
2024/20254.394 95 44 105 361 205 48 18 1.059 1.223 200 317 719
2025/202615.775 419 3.321 7.312 1.057 853 2.813 0 0 0 0 0 0
Totale 33.000